Navigation Links
Pulmo BioTech Inc. Announces Letter of Intent Regarding Proposed License of its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM)
Date:10/20/2009

duct candidates being developed by PulmoScience is believed by the company to be worth in excess of $500 million per annum.

About BioTechnology Consulting Poland Sp. z.o.o.

BioTechnology Consulting Poland Sp. z.o.o. is a Polish based company which has been set up to enable the rapid approval of products developed outside the Euro Zone in the European market.

Pursuant to the License Agreement contemplated by the LOI, BioTechnology Consulting Poland will license IP from Pulmo BioTech to enable it to rapidly carry out Phase Trials and ultimately commercialize PulmoBind across the whole of the European Union and European Economic Area.

BioTechnology Consulting Poland counts amongst its key staff, professionals in the areas of medical project management, new business start-up and growth, and medical Phase Trials. BioTechnology Consulting Poland has links with key Polish medical facilities, CROs and Pharmaceutical companies.

Further Information

For further information regarding Pulmo BioTech Inc. or PulmoScience, please visit www.pulmobiotech.com.

Forward-Looking Statements

Forward-looking statements contained in this and other written and oral reports are made based on known events and circumstances at the time of release, and as such, are subject in the future to unforeseen uncertainties and risks. All statements regarding future performance, earnings projections, regulatory approval, events or developments are forward-looking statements. It is possible that the future performance of the company may differ materially from current expectations, depending on economic conditions and the uncertainty of regulatory approval. A change in economic conditions may have a particularly volatile effect on results. Among the other factors which may affect future performance are: competitive market conditions and resulting effects on sales and pri
'/>"/>

SOURCE Pulmo BioTech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Unomedical Issues Worldwide Recall of Certain Manual Pulmonary Resuscitators
2. Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
3. AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA
4. FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
5. Positive Data From Lung Study May Lead to First FDA Approved Treatment for Pulmonary Fibrosis
6. Pulmo BioTech Inc. Announces Dual Listing on Frankfurt Borse
7. Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease
8. APTA Supports Surgeon Generals Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism
9. Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
10. Pulmo BioTech Inc. Completes Bio-Distribution Studies
11. Positive Mid-Term Results on CryoValve(R) SG Pulmonary Human Heart Valve Presented at Western Thoracic Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 02, 2015 Research and Markets ( http://www.researchandmarkets.com/research/g5r2nj/surgical_incision ... Closures - Global Strategic Business Report" report to their ... the US, Canada , Japan ... , Latin America , and Rest ... for Surgical Incision Closures in US$ Million by the following ...
(Date:6/2/2015)... 2, 2015 Intarcia Therapeutics, Inc. ... from its recently announced synthetic royalty / equity convert ... Investors have purchased Convertible Limited Recourse Notes from Intarcia ... 2.0% of any future global net sales of ITCA ... Investors also have the option, commencing upon U.S. regulatory ...
(Date:6/2/2015)... 2, 2015 Stoltenberg Consulting , ... today announced the celebration of its 20-year anniversary ... U.S., since its inception in 1995. ... in the healthcare technology industry continues, we strive ... dedication to facilitating clients, organizational goals, understanding that ...
Breaking Medicine Technology:Surgical Incision Closures - Global Strategic Business Report 2015 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 3Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 2Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 3
... JOLLA, Calif., Oct. 21 Transdel Pharmaceuticals, Inc. (OTC ... company focused on developing topically administered products using its ... John N. Bonfiglio, Ph.D. as Chief Executive Officer and ... on Transdel,s Board of Directors. With over ...
... the world,s leading research and advisory firms for pharmaceutical and ... drug market will remain relatively flat, increasing from $2.8 billion ... States, France, Germany, Italy, Spain, United Kingdom and Japan. ... Epilepsy forecast a decline in overall sales through ...
Cached Medicine Technology:Transdel Pharmaceuticals Appoints John N. Bonfiglio, Ph.D. as Chief Executive Officer and President 2Transdel Pharmaceuticals Appoints John N. Bonfiglio, Ph.D. as Chief Executive Officer and President 3The Epilepsy Drug Market Will Remain Relatively Flat Through 2019 as Generic Erosion, Especially Within the Second-Generation Antiepileptic Drug Class, is Offset by the Launch of New Therapies 2
(Date:6/2/2015)... The nation’s first trial involving ... ) is now underway in California Superior Court, ... statements were presented on May 28th, with the ... Profemur hip replacement made the device brittle and ... three years after it had been implanted in ...
(Date:6/2/2015)... 02, 2015 Did you wish Ryder Weise ... get him, his family isn’t asking for presents, but instead ... walking in Saturday’s Cure HHT DC Walk. , Ryder was ... causes malformed blood vessels leading to sudden and extreme bleeding ... when Ryder was 3 years old in the form of ...
(Date:6/2/2015)... Sunrise, FL (PRWEB) June 02, 2015 ... contract staffing services to healthcare facilities, today announced the ... simple and effective mobile tool to help candidates find ... a Glassdoor survey released in 2014, 9 in 10 ... device during their job search. , The MedPro Top ...
(Date:6/2/2015)... 02, 2015 IMPAK Corporation, a ... has announced the availability of “child-resistant” pouches and ... by children, especially curious toddlers. The Child Resistant ... tested to CFR 1700.20 protocols. The announcement was ... Looks Like Candy, “With the proliferation of consumer ...
(Date:6/2/2015)... Mo. (PRWEB) June 02, 2015 With a ... Senior Living & Health Care has hired Leslie Young ... expansion of human resource initiatives to better understand and respond ... families in Tutera’s 47 communities in 13 states across the ... highest levels of personalized support to our residents, we are ...
Breaking Medicine News(10 mins):Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 2Health News:First of More Than 1,200 Wright Hip Lawsuits Goes to Trial in California Superior Court 3Health News:Six-Year-Old Walks to Bring Awareness to Genetic Disease 2Health News:MedPro Healthcare Staffing Launches New MedPro Top Jobs App To Facilitate Job Search For Healthcare Professionals 2Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 3Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 4
... 29 Ingenious Med, the leader in inpatient,practice ... the,company approaches exciting new milestones. Record sales and ... Ingenious Med even closer to,the 4,000 user mark, ... of,2008. In addition, the company expects to reach ...
... majority of general internists and pediatricians in the United ... for young adults with complex chronic illnesses that originate ... survey. , The survey, conducted by researchers at the ... Michigan, examined a random sample of internists and pediatricians ...
... reliable results , , TUESDAY, July 29 (HealthDay News) -- ... care and research, but most tests aren,t administered according ... Center researchers. , In cancer care, exercise tests are ... patients. In cancer research, exercise tests are most often ...
... 40 years of ... brand marketing expertise, CHICAGO, July 29 The Cambridge Group, ... firm as a director., Mr. Marineau brings 40 years of ... to the firm. He,recently retired as president and CEO of Levi ...
... YORK, July 29 Care Investment Trust Inc.,(NYSE: ... quarter 2008,financial results before the market opens on Tuesday, ... conference call on Tuesday, August 12, 2008, at,11:00 a.m. ... call may,be accessed live by dialing 800-240-7305 or by ...
... may leave a mark on the brain, by changing ... and problems with attention. For one in six Americans ... often trigger more frequent urges to urinate, such mind-body ... , "We often tend to focus on just one ...
Cached Medicine News:Health News:Ingenious Med Continues Record Customer Growth and Approaches Key Milestones 2Health News:Ingenious Med Continues Record Customer Growth and Approaches Key Milestones 3Health News:Most generalists reluctant to provide primary care for young adults with chronic illness 2Health News:Most generalists reluctant to provide primary care for young adults with chronic illness 3Health News:Exercise Testing for Cancer Fails to Follow Guidelines 2Health News:The Cambridge Group Names Philip Marineau a Director 2Health News:Findings on bladder-brain link may point to better treatments for problems in sleep, attention 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: